Frequently Asked Questions

Our FAQ page offers essential details about Chirayu Super Speciality Hospital's services, treatments, and appointment booking. Find answers to common questions about our specialized medical care, diagnostic tests, and treatment options. This resource ensures a smooth, informed experience when accessing our comprehensive healthcare services.

1. PT / INR

The target INR range for patients on warfarin therapy varies depending on their condition but is typically between 2.0 and 3.0.

Frequency of testing depends on individual patient needs, but initially, it may be done weekly or bi-weekly until stable, then less frequently thereafter.

Yes, the PT / INR Test can help diagnose various clotting disorders, including those related to liver disease or genetic clotting factor deficiencies.

Medications, dietary changes, liver function, and underlying health conditions can all influence PT / INR results.

Yes, the PT / INR Test is a safe and standard diagnostic procedure used worldwide to monitor blood clotting ability and adjust anticoagulant therapy.

2. What is ACL reconstruction surgery?

ACL reconstruction surgery involves replacing a torn anterior cruciate ligament in the knee with a graft to restore stability.

3. 24 HRS URINE PROTEIN

If you miss a sample, it is crucial to contact the hospital for guidance. You may need to start the collection period again to ensure accurate results.

Most medications can be taken as usual, but it’s important to inform your healthcare provider about any medications or supplements you are using.

It’s essential to collect all urine during the 24-hour period. If you experience a spill or loss, contact the hospital to determine the best course of action.

The collected urine should be kept refrigerated throughout the collection period to preserve its integrity.

Results are typically available within 1 to 3 days after the sample is submitted to the laboratory. Your healthcare provider will review the results with you and discuss any necessary follow-up steps.